Summary.-Previous studies have characterized the enzymatic properties and inhibition of a trypsin-like neutral protease on the surface of Ehrlich ascites cells by means of kinetic analysis. The present study links these kinetic studies with the recently reported role of a tumour-cell membrane-bound serine protease in tumourinduced target cell lysis. Low-mol.-wt inhibitors of this cell-surface trypsin-like neutral protease exhibited a corresponding ability to prevent tumour-induced haemolysis. High-mol.-wt inhibitors of trypsin in free solution had no inhibitory action either on the tumour-bound enzyme or on the ability of tumour cells to lyse erythrocytes. Fragments of tumour-cell membrane retain both the trypsin-like neutral protease activity and the ability for haemolysis. This study represents a correlation between an easily assayed membrane-bound enzyme on tumour cells and a function of possible biological relevance.
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EARLIER STUDIES with Ehrlich ascites tumour cells grown in mice (Steven et al., 1980; Short et al., 1981) demonstrated that these cells possessed a trypsin-like neutral protease located on the cell surface. This neutral protease was further demonstrated to be protected from the approach of highmol.-wt inhibitors of trypsin but was inhibited by peptides derived by pronase digestion of these high-mol.-wt inhibitors . It was concluded that low-mol.-wt reagents which specifically inhibited this neutral protease on the surface of tumour cells might be capable of inhibiting the tumourigenic activity of such cells . It has recently become possible to test such a theory, employing the tumour-induced erythrocyte-cytolysis assay introduced by DiStefano et al. (1982) . These authors reported a membrane-bound trypsin-like enzyme on the surface of Walker 256 tumour cells which caused haemolysis of erythrocytes at 37°C after a lag period of 6 h in which no lysis was observed. The activity of this protease was much higher in a preparation of tumour-cell membranes than in preparation of intact tumour cells. This observation was in contrast to an earlier report by Zucker & Lysik (1977) in which it was claimed that tumourmediated cytotoxicity of erythroblasts required intact tumour cells. Our results clearly show that the presence of intact viable tumour cells is not a necessary requirement for target-cell lysis. Washed fragments of tumour-cell membrane are sufficient perse to promote target-cell lysis. All that the intact tumour cell provides is a suitably located neutral protease on its plasma membrane. Questions relating to the viability of the tumour cell and the possible effect of inhibitors used in these studies on the tumour-cell DNA can be disregarded as irrelevant to a discussion of control of tumour-cell-induced lysis of target cells, since fragments of tumour-cell membranes can replace intact viable cells in this assay.
We employed a similar haemolytic assay system, replacing the Walker 256 cells with mouse Ehrlich ascites tumour cells in the presence of incremental additions of reagents which had previously been shown to inhibit the cell-surface neutral protease (Short et al., 1981; . Our results indicate that metal-ion inhibition of the neutral proteasc on the tumour cells corresponds to a similar inhibition of haemolysis by tumour cells. Our evidence also indicates that the cell-surface neutral protease is directly responsible for the observed haemolysis and that there is no requirement for the release of soluble proteases from the tumour cell to promote lysis.
MATERIALS AND METHODS
Ehrlich ascites tumour cells were grown in mice (Itzhaki, 1972) centrifuge, 100 g, for 5 min to remove intact cells; the supernatant fraction containing the disrupted cell membranes was then centrifuged at 120,000 g for 1 h to collect a pellet of cell-membrane fragments. The pellet was washed by centrifugation in 0.9% NaCl 2 x and finally a suspension of membrane fragments in NaCl containing 30 mg protein/ ml was prepared.
Fresh normal human blood was suspended without anticoagulant in a large volume of 0-9% NaCl and rapidly centrifuged to remove plasma constituents. The erythrocytes were carefully washed 3 x in 0.9% NaCl and finally suspended in a medium containing 2mM glucose dissolved in 0.9% NaCl. The erythrocyte count of this suspension was adjusted to provide 109 cells/ml. Fresh human serum was also obtained from these donors. 62
Aprotinin supplied as the drug trasylol (10,000 k.i.u./ml) was kindly provided by
Bayer. The gold-containing anti-rheumatic drug Auranofin used in this study was donated by Smith, Kline and French Ltd; this was dissolved in water to give a stock solution containing 10 mg Auranofin/ml. The chemical structure of Auranofin is S-(triethylphosphoranediylaurio)-1 -thio -fi -D -glucopyranose 2,3,4,6-tetra-acetate. All reactions were carried out in screwcapped plastic bijou tubes. In each tube was placed 0 5 ml tumour-cell suspension or cellmembrane fragments, 2 ml of 2mm glucoseNaCl, plus 0-5 ml erythrocyte suspension. The incremental addition of potential inhibitors was made with a 0-100,ul microsyringe. The contents of the tubes were mixed and allowed to stand without shaking at 370C for 18 h.
The contents of the tubes were then stirred and centrifuged for 3 min at 200 g. The release of haemoglobin from the erythrocytes was measured by withdrawing lOO,ul aliquots from the clear supernatant fractions of each tube and placing this sample in 3 ml 0.9% NaCl before spectrometric analysis at 530 nm, the isosbestic point of haemoglobin and methaemoglobin (Joiner & Lauf, 1978) . The total haemoglobin content of the erythrocytes was determined on control tubes to which 100 ,tg of saponin had been added. We decided to arrange conditions so that the added tumour cells caused between 30 and 40% total haemolysis. The inhibition of tumour-cellinduced haemolysis is presented as a percentage of the effective haemolysis by tumour cells in the absence ofpotential inhibitors. For example, if the tumour cells caused 38 % haemolysis, then we would give this control the value of 100 on the vertical scale of Figs 1-3, whilst the horizontal axis defines the final concentration of potential inhibitor in the test system, having a total volume of 3 ml. In order to demonstrate that the intact living tumour cells were not a requirement for target-cell cytolysis, we employed a similar incremental addition of cell-membrane fragments to erythrocytes in 3 ml 0.9% NaCl containing 2mM glucose and incubated this mixture for 18 h at 370C. Haemolysis was measured as described above, and in this case the degree of haemolysis (Fig. 4) (Figs 3 & 4) . Lysis induced by tumour-cell-membrane fragments was also inhibited by Auranofin and ZnSO4; the data for ZnSO4 are presented in Fig. 3 . In order to demonstrate that lysis was independent of the presence of viable tumour cells, we employed incremental additions of tumour-cell-membrane fragments to a fixed number of erythrocytes and showed a direct relationship between the degree of haemolysis and the quantity of washed membrane protein added to the system (Fig. 4) (Heimburger, 1975) failed to inhibit tumour-induced haemolysis as would be predicted from our earlier studies. Similarly the reagent aprotinin (mol. wt , 12,000; Rifkin & Crowe, 1977) , with a wide specificity for proteolytic enzymes, haemolysis. Neither serum nor aprotinin is an effective inhibitor of the cell-surface trypsin-like enzyme of Ehrlich ascites tumour cells (Steven et al., 1980; . Free trypsin was unable to cause haemolysis, which may also indicate that enzymes in free solution are not responsible for the observed haemolysis. Metal ions, which have been shown to be good inhibitors of cell-bound neutral proteases on tumour and sperm cells (Short et al., 1981; were good inhibitors of tumour-induced haemolysis (Figs 1-3) . It should be pointed out that direct comparisons cannot be made between the molarity of metal ions required to cause inhibition of tumour-cellsurface P-naphthylamidase activity (Short et al., 1981) and inhibition of tumourmediated haemolysis, since the erythrocytes will also bind metal ions and alter the effective ionic concentration in the test system. It is clear, however, that good (Fig. 3) can be inhibited by Zn++, etc., these inhibitors control this enzyme directly, rather than by influencing the tumour-induced cytolysis through modification of tumour DNA. Zn++ is almost equally as effective in inhibiting haemolysis by the membrane fragments ( Fig. 3) and by intact tumour cells (Fig. 2) .
We believe the results presented above strengthen the claim made by DiStefano et at. (1982) that tumour-induced target-cell lysis is mediated by a membrane-bound protease which is similar to trypsin and which may be assayed by the fluorescent /-naphthylamidase assay (Short et al., 1981) . This study therefore links the previously reported kinetic studies (Steven et al., 1980; Short et al., 1981) of the tumour-cellsurface neutral protease and the study of its inhibition, with one of the observable biological properties of tumour cells, namely target cytolysis (DiStefano et al., 1982) . We believe further studies of the selective inhibition of this important cellsurface neutral protease could lead to further developments in the control of the biological properties of tumour cells, for example cell lysis and the generation of proteolytic enzymes of crucial importance in the pathophysiology of cancer invasion.
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